Latest News

Qimono drug compatibility proven

Tests to evaluate the compatibility of Qimono, Vygon’s closed system transfer device, with key cancer therapies have concluded the connectors would be compatible with all cytotoxic drug infusions in current clinical practice. The testing conducted by Professor Graham...

read more

New study shows big contamination risk reduction

A new clinical study from the US shows a reduction in contamination risk of 97% when using a closed system transfer device (CSTD) to administer hazardous drugs. The US study* involved 13 cancer centres across the United States and the findings demonstrated...

read more

Papers Supporting CSTD

A key paper has been published recently showing a reduction in contamination risk of 97% when using a CSTD during administration of hazardous drugs, vs no CSTD. S.Bartel et al 2018 Pharmacy. Dana Farber Cancer institute Boston MA. The paper found that out...

read more